|
Tuesday 20th June 2023 |
Text too small? |
Auckland, New Zealand, 20 June 2023 - Fisher & Paykel Healthcare Corporation Limited attaches a copy of its presentation for the ASX’s CEO Connect webinar to be held later today.
There is no new material information contained within the presentation.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Media & Investor Contacts:
Hayden Brown
Head of Capital Markets & Investor Relations
hayden.brown@fphcare.co.nz
+64 (0) 27 807 8073
Dan Adolph
Senior Communications & Investor Relations Manager
daniel.adolph@fphcare.co.nz
+64 (0) 22 511 4050
Authorised by Raelene Leonard, General Counsel and Company Secretary.
No comments yet
CVT - Comvita Rights Offer Opens
GNE - FY26 Q3 Performance Report and Updated Guidance
April 23rd Morning Report
Devon Funds Morning Note - 22 April 2026
AGL - Accordant Group Limited announces opening of Rights Offer
April 22nd Morning Report
BPG - Q4 FY26 Update: ARR reaches $26.8m
Devon Funds Morning Note - 21 April 2026
April 21st Morning Report
CHI - Government diesel storage at Marsden Point